Disease staging: CliniCal anD CoDeD Criteria - HCUP

Clinical Criteria with Description, Diagnostic Findings and ICD-9-CM codes
DXCat Number: INF04
MultiStage: No
DXCat Label: Chlamydial Infection Except Trachoma or Pneumonia Specificity: A
Etiology: Infection
Stage Description Diagnostic findings ICD-9-CM Codes
0.00 Screening exam for chlamydia
DX V7388, V7398;
1.01 Chlamydial conjunctivitis Mucopurulent conjunctival discharge
DX 07798, 07888, 07988, 07998,
OR conjunctival injection
09950, 09959;
OR conjunctival edema
AND chlamydial trachomatis [exudate culture report]
OR chlamydial trachomatis
[immunofluorescence antibody report or ELISA report or DNA-PCR report]
1.02 Chlamydial proctitis Proctitis
AND
chlamydial trachomatis [immunofluorescence antibody report or ELISA report or DNA-PCR
report]
1.03 Chlamydial urethritis Urethritis
AND chlamydial trachomatis [immunofluorescence antibody report or ELISA report or DNA-PCR
report]
1.04 Chlamydial cervicitis Cervicitis
AND chlamydial trachomatis [immunofluorescence antibody report or ELISA report or DNA-PCR
report]
2.01 with lymphogranuloma venereum Stage 1.01-1.04
AND suppurative inguinal lymphadenitis
DX 09952;
DX 09941, 09951, 09953, 09955;
STAGE 1.01-1.03 + DX 6160;
STAGE 1.01-1.04 + (DX 2891-
2893, 683, 7856 OR DXCAT INF17);
2.02 Chlamydial infection with pelvic
inflammatory disease
Stage 1.01-2.01
OR pelvic inflammatory disease
AND chlamydial trachomatis [immunofluorescence antibody report or ELISA report or
DNA-PCR report]
DX 09954, 09956;
DX 09954 + DX 6140-6149;
DX 09956 + DX 6140-6149;
STAGE 1.01-2.01 + DX 6140-6149;
2.03 Chlamydial interstitial pneumonia Stage 1.01-2.02
AND new infiltrate [chest x-ray report]
3.01 with respiratory failure Stage 1.01-2.03
AND respiratory failure:
3.02 with shock Stage 1.02-3.01
AND shock:
4.00 with death Stage 1.02-3.02
AND death
STAGE 1.01-2.02 + (DX 4808-
4809, 485-486, 5168);
STAGE 1.01-2.03 + GROUP
RESP_FAIL;
STAGE 1.01-3.01 + (GROUP
SHOCKC OR GROUP SHOCKN) ;
NO;
Thursday, January 07, 2010 9:22:21 AM
©2010 Thomson Reuters. All rights reserved.